Trials / Unknown
UnknownNCT01162941
Efficacy of Helicobacter Pylori Eradication, Anti-D and Danazol Combination in Steroid Dependant or Refractory Immune Thrombocytopenia (ITP)
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 38 (estimated)
- Sponsor
- Cooperative Study Group A for Hematology · Network
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Proportion who would avoid splenectomy at 6 months of follow up
Detailed description
1. If urea breath test (+); omeprazole 20mg bid, amoxicillin 1000mg bid and clarithromycin 500mg bid for 1 week. Second line Helicobacter pylori eradication will be permitted after failure of first line treatment. 2. Anti-D Anti-Ro 50 μg/kg IV for 2 days (D1, 2) 3. Danazol maintenance (from D1): Danazol will be continued at least 3 months. The dose of danazol can be reduced according to the adverse effects, especially in premenopausal women.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Steroid refractory ITP | a platelet count less than 20X109/L despite of treatment with full dose of steroid (prednisolone 1mg/kg for at least 4 weeks) |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2011-07-01
- Completion
- 2012-01-01
- First posted
- 2010-07-15
- Last updated
- 2010-07-15
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01162941. Inclusion in this directory is not an endorsement.